Recharging aged-CAR with NAD+ to boost immunotherapy
Trends in Cancer · 2025
DOI: 10.1016/j.trecan.2025.06.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Cancer, 2025. Verfasst von Gaofeng Fan und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Electronic address: fangf@shanghaitech.edu.cn. Hauptthemen laut MEDLINE: NAD, Neoplasms, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Impaired cellular metabolism contributes to the age-related decline in T cell function, undermining the response to immunotherapy in older patients with cancer. In a recent study, Hope et al. report that a reduction in intracellular NAD+ levels compromises metabolic fitness and drives immunosenescence. Notably, restoring NAD+ levels can reverse age-related chimeric antigen receptor (CAR)-T deterioration, suggesting a promising 'metabolic immunotherapy' that widely benefits older patients with cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Electronic address: fangf@shanghaitech.edu.cn.
- School of Life Science, Fudan University, Shanghai, China.
- Center for Childhood Cancer Research, Hematology/Oncology & BMT, Abigail Wexner Research Institute at Nationwide Children's Hospital, Ohio State University, Columbus, OH, USA. Electronic address: ruoning.wang@nationwide…
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Fan, G., Wang, Y., & Wang, R. (2025). Recharging aged-CAR with NAD+ to boost immunotherapy. Trends in Cancer. https://doi.org/10.1016/j.trecan.2025.06.009
Vancouver
Fan G, Wang Y, Wang R. Recharging aged-CAR with NAD+ to boost immunotherapy. Trends in Cancer. 2025. doi:10.1016/j.trecan.2025.06.009
BibTeX
@article{Fan2025,
author = {Fan, Gaofeng and Wang, Yuetong and Wang, Ruoning},
title = {Recharging aged-CAR with NAD+ to boost immunotherapy},
journal = {Trends in Cancer},
year = {2025},
doi = {10.1016/j.trecan.2025.06.009}
}
EUVIMED